HK1217443A1 - 用於糖尿病的口服治療的藥物組合物 - Google Patents

用於糖尿病的口服治療的藥物組合物

Info

Publication number
HK1217443A1
HK1217443A1 HK16105525.5A HK16105525A HK1217443A1 HK 1217443 A1 HK1217443 A1 HK 1217443A1 HK 16105525 A HK16105525 A HK 16105525A HK 1217443 A1 HK1217443 A1 HK 1217443A1
Authority
HK
Hong Kong
Prior art keywords
diabetes
pharmaceutical compositions
oral treatment
oral
treatment
Prior art date
Application number
HK16105525.5A
Other languages
English (en)
Inventor
亞歷山大‧沃爾
歐娜．格里博瓦
Original Assignee
Oshadi Drug Administration Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oshadi Drug Administration Ltd filed Critical Oshadi Drug Administration Ltd
Publication of HK1217443A1 publication Critical patent/HK1217443A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16105525.5A 2013-01-29 2016-05-13 用於糖尿病的口服治療的藥物組合物 HK1217443A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361757762P 2013-01-29 2013-01-29
US201361880996P 2013-09-23 2013-09-23
PCT/IL2014/050099 WO2014118774A1 (en) 2013-01-29 2014-01-29 Pharmaceutical compositions for oral treatment of diabetes

Publications (1)

Publication Number Publication Date
HK1217443A1 true HK1217443A1 (zh) 2017-01-13

Family

ID=51261551

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16105525.5A HK1217443A1 (zh) 2013-01-29 2016-05-13 用於糖尿病的口服治療的藥物組合物

Country Status (7)

Country Link
US (1) US20150366946A1 (zh)
EP (1) EP2950809A4 (zh)
CN (1) CN105073129A (zh)
AU (1) AU2014210751A1 (zh)
CA (1) CA2899220A1 (zh)
HK (1) HK1217443A1 (zh)
WO (1) WO2014118774A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170028031A1 (en) * 2014-03-07 2017-02-02 Klavs Holger Jørgensen Novel fast acting insulin preparations
WO2015155151A1 (en) * 2014-04-07 2015-10-15 Novo Nordisk A/S Double-acylated glp-1 compounds
WO2016205754A1 (en) 2015-06-19 2016-12-22 University Of Southern California Compositions and methods for modified nutrient delivery
WO2016205701A1 (en) 2015-06-19 2016-12-22 University Of Southern California Enteral fast access tract platform system
CN110179997B (zh) * 2018-08-08 2020-02-14 昆山新蕴达生物科技有限公司 一种用于糖尿病治疗的纳米药物载体及其组合药物
EP3996731A4 (en) * 2019-07-12 2023-07-12 Op-T Llc PEPTIDES AND METHODS OF TREATING DISEASES
WO2021053246A1 (en) * 2019-09-20 2021-03-25 University College Dublin Oral delivery system
CN112667922B (zh) * 2021-01-12 2022-06-28 山东大学 基于协同过滤的新型冠状病毒中药组方推荐方法及系统
CA3236023A1 (en) 2021-10-19 2023-04-27 Tijani Holding B.V. Biosoluble polymer or particle for delivery of an active agent and a method for the production
CN115487288B (zh) * 2022-09-28 2024-03-01 重庆三峡学院 一种杏仁肽口服液及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DOP1982004086A (es) * 1981-08-27 1988-03-22 Lilly Co Eli Formula farmaceutica que comprende insulina humana y proinsulina humana
US4652548A (en) * 1981-08-27 1987-03-24 Eli Lilly And Company Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
CN1219548C (zh) * 2001-05-18 2005-09-21 上海益众生物技术有限公司 C肽联合胰岛素治疗糖尿病并发症及c肽专一性抗体
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
CN101297963A (zh) * 2007-04-30 2008-11-05 上海新生源医药研究有限公司 一种胰岛素原c肽的药物组合
IL188647A0 (en) * 2008-01-08 2008-11-03 Orina Gribova Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)

Also Published As

Publication number Publication date
CN105073129A (zh) 2015-11-18
WO2014118774A1 (en) 2014-08-07
US20150366946A1 (en) 2015-12-24
EP2950809A1 (en) 2015-12-09
CA2899220A1 (en) 2014-08-07
AU2014210751A1 (en) 2015-08-06
EP2950809A4 (en) 2016-09-14

Similar Documents

Publication Publication Date Title
IL246377A0 (en) Pharmaceutical preparations for oral administration
IL239735B (en) A pharmaceutical preparation for the treatment of diseases related to toxic aldehyde
HK1217443A1 (zh) 用於糖尿病的口服治療的藥物組合物
EP2968071A4 (en) DEVICE FOR THE ORAL RELEASE OF THERAPEUTIC COMPOUNDS
HUE044611T2 (hu) Gyógyászati készítmény rák kezelésére
PT2824114T (pt) Composição farmacêutica para o tratamento do cancro
EP3038465A4 (en) Oral pharmaceutical formulation of omarigliptin
HK1199821A1 (zh) 口服用醫藥組合物
HK1199822A1 (zh) 口服給藥用醫藥組合物
PT3524260T (pt) Composições farmacêuticas para o tratamento de inapetência
PT2859896T (pt) Composições farmacêuticas para o tratamento de distúrbios musculares
ZA201508452B (en) Oral formulation for the treatment of cardiovascular diseases
HUE037176T2 (hu) Olaj-alapú gyógyszerészeti készítmény gasztrointesztinális betegségek kezelésére
ZA201604100B (en) Gastro-retentive oral pharmaceutical compositions
EP2979698A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
IL240119A0 (en) Pharmaceutical compositions for oral treatment of diabetes
GB201407847D0 (en) Composition for the oral delivery of compounds
PL2812351T3 (pl) Kompozycja farmaceutyczna do leczenia stwardnienia rozsianego